Boston Children's Hospital Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Boston Children's Hospital Dana Farber Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects.
Sponsors: John Levine.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boston Children's Hospital Dana Farber Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boston Children's Hospital Dana Farber Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects.
Boston Children's Hospital Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.